US FDA approves first generic capecitabine of Teva Pharmaceuticals
To treat colorectal and breast cancers
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Debiopharm Group in research agreement with TCG Lifesciences
To develop a novel class of antibiotics, a new strategic therapeutic area for Debiopharm
WHO evaluates Panacea Biotec’s pentavalent vaccine
Successfully completes the audit of its Lalru and Baddi facilities, conducted by WHO team
Dr Yusuf Hamied, CMD, Cipla, to deliver first Margi Memorial lecture
Announcement will be made about the proposed Margi Patel Choksi Memorial IPR Foundation
Rupee’s fall from grace: A blessing in disguise?
How will the falling Rupee impact Indian pharma Inc? While some feel it's an unmitigated disaster, others call it a blessing in…
‘Companies need to proactively hedge their risks and minimise impact on their earnings’
The Indian rupee has depreciated significantly against the dollar, raising anxieties amongst many stakeholders in the country.…
‘Exports will encash the benefit’
Depreciating rupee shall have mixed impact on the sector. Companies which are highly dependent on exports or more than 50 per cent…
‘The rupee depreciation has happened at the wrong time for the pharma industry’
The Indian rupee is under great stress as overseas investors are paring their exposure to Asia’s third largest economy amid…
‘Rupee depreciation is expected to increase manufacturing costs’
The rupee’s weakness unfolded when it depreciated over 16 per cent against the US dollar between January 2013 and July 2013. With…